Drug Interaction Potentiation

A Drug-Drug Interaction Study of Digoxin and PA21

NCT01477411 | PHASE 1 | INTERVENTIONAL

The purpose of this study is to determine if Digoxin is affected by PA21.

1 Sites

42 Participants

Recruiting

20 Years to 50 Years

If interested, contact clinicaltrials@cslbehring.com for more information

CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy

Find closest sites:

SUBMIT

ACRI Phase

Anaheim,California,United States,92801

Study Eligibility Criteria

Inclusion Criteria

* Healthy volunteers
* Written informed consent

Exclusion Criteria

* No significant medical conditions
* Pregnancy

Additional Studies

Additional studies can be found at ClinicalTrials.gov